Vaccination News

Moderna announced positive interim results from a phase 3 trial of its next-generation COVID-19 vaccine, which the company said will help pave the way for its combination shot against COVID-19 and influenza.

The role of serologic testing for SARS-CoV-2 has evolved during the pandemic, leading the Infectious Diseases Society of America to update its guidance.

Use of an influenza vaccine messaging platform in EDs increased vaccine uptake among unvaccinated patients, a study in NEJM Evidence showed.

An annual COVID-19 vaccination campaign, in which second doses were administered to certain at-risk populations, was associated with reduced disease burden and health care costs, a study showed.

The cost-effectiveness of routine COVID-19 testing among nursing home staff depended on the virulence of variants circulating during the time of testing, researchers found.

A task force supported by the Pediatric Infectious Diseases Society recently published the first guidance for the prevention and treatment of COVID-19 in children in the vaccine era.

Cases of multisystem inflammatory syndrome in children increased by nearly two-thirds last fall, aligning with an increase in COVID-19 activity, according to a study published in MMWR.

DENVER — Among people with HIV, hybrid immunity against COVID-19 is more effective at preventing infection and severe disease than vaccination alone, according to a study.

DENVER — SARS-CoV-2 antigens persist in patients with COVID-19 for months to years after infection, according to data presented at the Conference on Retroviruses and Opportunistic Infections.

The latest COVID-19 vaccines reduce the risk for hospitalization or visits to an ED or urgent care by around 50%, according to interim data published in MMWR.